Roberts Kent Charles II 4
4 · BIOLARGO, INC. · Filed Oct 5, 2022
Insider Transaction Report
Form 4
BIOLARGO, INC.BLGO
Roberts Kent Charles II
Director
Transactions
- Award
Option to Purchase Common Stock
2022-10-03+55,556→ 2,477,251 totalExercise: $0.27From: 2022-10-03Exp: 2032-10-03→ Common stock (55,556 underlying) - Award
Option to Purchase Common Stock
2022-10-03+23,750→ 2,501,001 totalExercise: $0.27From: 2022-10-03Exp: 2032-10-03→ Common stock (23,750 underlying)
Footnotes (3)
- [F1]This Option was issued to Reporting Person as payment for $15,000 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2018 Equity Incentive Plan.
- [F2]The total reflects the October 2, 2022 expiration of options to purchase 47,500 shares of Issuer's common stock.
- [F3]This Option was granted to Reporting Person to replace an option that had been issued approximately 10 years ago to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee.